Concanavalin A cap formation on human polymorphonuclear leukocytes induced by R17934, a new antitumor drug that interferes with microtubule assembly.
D000970:Antineoplastic Agents / Q000494:pharmacology*; D001562:Benzimidazoles / Q000494:pharmacology*; D001665:Binding Sites / Q000187:drug effects; D002219:Carbamates / Q000494:pharmacology; D002462:Cell Membrane / Q000276:immunology; D003078:Colchicine / Q000494:pharmacology; D003208:Concanavalin A; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007700:Kinetics; D008870:Microtubules / Q000187:drug effects*; D009504:Neutrophils / Q000187:drug effects* / Q000276:immunology
D000970:Antineoplastic Agents; D001562:Benzimidazoles; D002219:Carbamates; D003208:Concanavalin A; D003078:Colchicine